Vaccine Cost Controversy

Rediff.com » News » Vaccine Cost Controversy

News for Vaccine Cost Controversy

News
Business
Sports

Dom's Take: The Vaccine Cost Controversy

Dominic Xavier offers his take on the controversy over the cost of the COVID-19 vaccine post May 1. Dom's Take...

All citizens to get free COVID-19 vaccine: Union minister

Union minister Pratap Sarangi on Sunday said that all people of the country will be given free COVID vaccine, amidst the demand by opposition parties in the country for it and not only in......

Covid vaccine to be distributed under special programme: Officials

As a controversy raged over Bharatiya Janata Party's election manifesto promising free coronavirus vaccine for everyone in Bihar, government officials on Thursday said the vaccine, once ready, will......

How Serum and Bharat battled for COVID-19 vaccine

There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it.One senior person, who was very familiar with the sector, told me, 'The message has......

'We will be prioritising vaccine only for India'

'I don't think anybody would want to be in my position today where every head of State has to be explained that I am prioritising my country because there is a surge in cases.' IMAGE: Vaccination......

Onsite demand may pick up for IT firms in US, UK

To be able to manage any such uptick, Indian IT services players are hiring more locals, and relying on hybrid work models. Illustration: Uttam Ghosh/Rediff.com With major markets like the US, UK,......

7 key challenges Madhabi Puri Buch faces as new Sebi chief

Having demitted office as a whole-time member in October 2021, she must be fully aware of the challenges and the tasks ahead. Samie Modak reports. Illustration: Dominic Xavier/Rediff.com Madhabi......

When R K Krishna Kumar Spoke To Rediff

R K Krishna Kumar, one of the stalwarts of the Tata group, passed away on Sunday, January 1, 2023, evening. A close lieutenant of then Tata Sons chairman Ratan Tata, he spoke to Rediff.com's......

Indian pharma cos shifting R&D to SE Asian countries

Indian pharma companies are shifting research and development operations and clinical trials to South-East Asian countries due to transparent regulations and sops offered by these nations, a survey......

The 10 biggest policy mistakes of the past

India still has a long way to go as far as economic recovery is concerned and constraints go back several decades, notes Shankar Acharya As monsoon showers blanket the country, the prevailing......

Australian government cancels Djokovic visa again

IMAGE: A relaxed looking Novak Djokovic practised his serves and returns with his entourage on an empty court at Melbourne Park on Friday. Photograph: Daniel Pockett/Getty Images Australia......

Tokyo Olympics chief Mori set to quit over sexist remark

Tokyo 2020 Olympics organising committee chief Yoshiro Mori's resignation would be bound to raise new doubts over the viability of holding the postponed Games this year. IMAGE: Yoshiro Mori made......